Follow
Sarah R Amend
Title
Cited by
Cited by
Year
Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment
KV Myers, SR Amend, KJ Pienta
Molecular cancer 18 (1), 94, 2019
2962019
Murine hind limb long bone dissection and bone marrow isolation
SR Amend, KC Valkenburg, KJ Pienta
JoVE (Journal of Visualized Experiments), e53936, 2016
2872016
Integrins and bone metastasis: integrating tumor cell and stromal cell interactions
JG Schneider, SR Amend, KN Weilbaecher
Bone 48 (1), 54-65, 2011
1962011
Polyploid giant cancer cells: Unrecognized actuators of tumorigenesis, metastasis, and resistance
SR Amend, G Torga, KC Lin, LG Kostecka, A de Marzo, RH Austin, ...
The Prostate 79 (13), 1489-1497, 2019
1422019
Comprehensive evaluation of methods for small extracellular vesicles separation from human plasma, urine and cell culture medium
L Dong, RC Zieren, K Horie, CJ Kim, E Mallick, Y Jing, M Feng, ...
Journal of extracellular vesicles 10 (2), e12044, 2020
1312020
Ecology meets cancer biology: the cancer swamp promotes the lethal cancer phenotype
SR Amend, KJ Pienta
Oncotarget 6 (12), 9669, 2015
1042015
Revisiting seed and soil: examining the primary tumor and cancer cell foraging in metastasis
AE De Groot, S Roy, JS Brown, KJ Pienta, SR Amend
Molecular Cancer Research 15 (4), 361-370, 2017
1032017
Cancer recurrence and lethality are enabled by enhanced survival and reversible cell cycle arrest of polyaneuploid cells
KJ Pienta, EU Hammarlund, JS Brown, SR Amend, RM Axelrod
Proceedings of the National Academy of Sciences 118 (7), e2020838118, 2021
762021
Antagonizing integrin β3 increases immunosuppression in cancer
X Su, AK Esser, SR Amend, J Xiang, Y Xu, MH Ross, GC Fox, ...
Cancer research 76 (12), 3484-3495, 2016
762016
Identifying key questions in the ecology and evolution of cancer
AM Dujon, A Aktipis, C Alix‐Panabières, SR Amend, AM Boddy, JS Brown, ...
Evolutionary Applications 14 (4), 877-892, 2021
682021
Convergent evolution, evolving evolvability, and the origins of lethal cancer
KJ Pienta, EU Hammarlund, R Axelrod, SR Amend, JS Brown
Molecular Cancer Research 18 (6), 801-810, 2020
672020
CXCR4 protein epitope mimetic antagonist POL5551 disrupts metastasis and enhances chemotherapy effect in triple-negative breast cancer
J Xiang, MA Hurchla, F Fontana, X Su, SR Amend, AK Esser, GJ Douglas, ...
Molecular cancer therapeutics 14 (11), 2473-2485, 2015
622015
Poly‐aneuploid cancer cells promote evolvability, generating lethal cancer
KJ Pienta, EU Hammarlund, R Axelrod, JS Brown, SR Amend
Evolutionary Applications 13 (7), 1626-1634, 2020
612020
Thrombospondin‐1 regulates bone homeostasis through effects on bone matrix integrity and nitric oxide signaling in osteoclasts
SR Amend, O Uluckan, M Hurchla, D Leib, D Veis Novack, M Silva, ...
Journal of Bone and Mineral Research 30 (1), 106-115, 2015
582015
Cancer cells employ an evolutionarily conserved polyploidization program to resist therapy
KJ Pienta, EU Hammarlund, RH Austin, R Axelrod, JS Brown, SR Amend
Seminars in cancer biology 81, 145-159, 2022
522022
Ecological paradigms to understand the dynamics of metastasis
SR Amend, S Roy, JS Brown, KJ Pienta
Cancer letters 380 (1), 237-242, 2016
492016
AXL is a putative tumor suppressor and dormancy regulator in prostate cancer
HD Axelrod, KC Valkenburg, SR Amend, JL Hicks, P Parsana, G Torga, ...
Molecular Cancer Research 17 (2), 356-369, 2019
482019
Interplay between cell death and cell proliferation reveals new strategies for cancer therapy
LV Loftus, SR Amend, KJ Pienta
International journal of molecular sciences 23 (9), 4723, 2022
412022
ROS-induced cell cycle arrest as a mechanism of resistance in polyaneuploid cancer cells (PACCs)
MD Kuczler, AM Olseen, KJ Pienta, SR Amend
Progress in biophysics and molecular biology 165, 3-7, 2021
412021
Updating the definition of cancer
JS Brown, SR Amend, RH Austin, RA Gatenby, EU Hammarlund, ...
Molecular Cancer Research 21 (11), 1142-1147, 2023
382023
The system can't perform the operation now. Try again later.
Articles 1–20